title: Suppression of contact sensitivity by local hyperthermia treatment due to reduced Langerhans cell population in mice.
abstract: The effects of local hyperthermia treatment on contact sensitivity (CS) and on the number of Langerhans cells (LCs) were studied in mice. CS was significantly suppressed when mice were sensitized in the hyperthermia treated skin I, 2 or 4 days after treatment (43 degrees C for 45 min). This suppressive effect was not observed 7 or 14 days after the treatment. CS was also suppressed when mice were sensitized in non-treated skin I day after the treatment. The density of LCs detected as ATPase-positive cells also decreased significantly 1, 2, 4 and 7 days after the treatment. There appeared to be a positive correlation between the number of LCs and the extent of CS when mice were sensitized at hyperthermia treated skin. It was observed that this suppressive effect on CS was dose- and temperature-dependent. It could be transferred by spleen cells from the hyperthermia treated and DNFB-sensitized donors, and was antigen specific when spleen cells were transferred before sensitization of the recipient mice. This indicated it was, in part, associated with the induction of suppressor cells. These findings suggest that local hyperthermia treatment reduces the number of LCs with subsequent suppression of the induction phase of delayed-type hypersensitivity by the generation of antigen-specific suppressor cells.
authors.affiliation: Department of Dermatology, Faculty of Medicine, Kyoto University, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Yoshioka
authors.forename: Y
authors.initials: Y
authors.lastname: Miyachi
authors.forename: S
authors.initials: S
authors.lastname: Imamura
authors.forename: M
authors.initials: M
authors.lastname: Hiraoka
authors.forename: S
authors.initials: S
authors.lastname: Jo
authors.forename: M
authors.initials: M
authors.lastname: Abe
mesh_terms: D000818:Animals; D002452:Cell Count; D003877:Dermatitis, Contact / Q000276:immunology / Q000628:therapy*; D004139:Dinitrofluorobenzene / Q000276:immunology; D005260:Female; D006358:Hot Temperature / Q000627:therapeutic use*; D007116:Immunization, Passive; D007801:Langerhans Cells / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D008813:Mice, Inbred ICR; D010081:Oxazolone / Q000276:immunology; D013154:Spleen / Q000637:transplantation; D013696:Temperature
chemical_list: D010081:Oxazolone; D004139:Dinitrofluorobenzene